Pathophysiology of Dengue Fever
Dengue fever pathophysiology involves a biphasic process beginning with direct viral infection and replication in immune cells, followed by immune-mediated vascular endothelial dysfunction leading to plasma leakage, thrombocytopenia, and in severe cases, a mixed hypovolemic-cardiogenic shock syndrome.
Initial Viral Entry and Cellular Infection
The dengue virus (DENV), transmitted by Aedes aegypti or Aedes albopictus mosquitoes, enters the host through the skin where it first infects Langerhans cells (dendritic cells) 1. The virus uses its E-protein as a binding protein to gain cellular entry 2. Following initial infection, the virus disseminates into the bloodstream and targets:
- Monocytes and macrophages (primary replication sites)
- White blood cells (lymphocytes, neutrophils)
- Endothelial cells
- Hepatocytes and Kupffer cells
- Bone marrow stromal cells 2
Immune Response and Viral Recognition
Once inside host cells, the innate immune system recognizes viral components through pattern recognition receptors:
- MDA5 (melanoma differentiation-associated protein 5) detects viral double-stranded RNA
- RIG-I (retinoic acid-inducible gene-I) responds to viral nucleic acids
- These trigger type I interferon (IFN) production and activate NK cells, IFN-γ, and TNF-α responses 2
Critical Pathogenic Mechanisms
Antibody-Dependent Enhancement (ADE)
A key pathogenic mechanism occurs during secondary infection with a different DENV serotype 1, 3. Pre-existing antibodies from the first infection facilitate viral entry into Fcγ receptor-bearing cells rather than neutralizing the virus. This results in:
- Enhanced viral replication
- Increased cytokine release from immune cells
- Amplified inflammatory cascade 3
Endothelial Glycocalyx Disruption
The virus causes severe endothelial damage through multiple mechanisms 2, 4:
- Non-structural proteins (NS1) trigger upregulation of three endothelial sialidases (Neu1, Neu2, Neu3)
- These enzymes degrade the endothelial glycocalyx layer
- Matrix metalloproteinases (MMPs) are overproduced, further compromising vascular integrity
- Direct viral damage and inflammatory mediators compound endothelial dysfunction 1, 2
Plasma Leakage and Vascular Permeability
The compromised endothelial barrier leads to the hallmark feature of severe dengue 5, 4:
- Increased capillary permeability
- Plasma leakage into extravascular spaces
- Hemoconcentration (hematocrit increase ≥20%)
- Hypovolemia and potential shock
Importantly, vascular leak typically resolves within 48-72 hours of defervescence, but this creates a critical therapeutic window 4.
Hematologic Manifestations
Thrombocytopenia
Multiple mechanisms contribute to low platelet counts 6, 3:
- Direct viral infection of bone marrow stromal cells
- Immune-mediated platelet destruction
- Autoantibodies against platelet cells
- Peripheral consumption
Thrombocytopenia (≤100,000/mm³) combined with plasma leakage defines dengue hemorrhagic fever 5.
Coagulopathy
Bleeding results from 6:
- Severe thrombocytopenia
- Platelet dysfunction
- Coagulation factor abnormalities
- Vascular fragility
Cardiovascular Involvement: A Temporal Dissociation
Recent evidence reveals that cardiac dysfunction follows a distinct timeline from vascular leak, creating important clinical implications 4:
Febrile Phase
- Direct viral myocardial effects
- Endothelial glycocalyx disruption begins
Defervescence Phase
- Immune-mediated myocardial injury peaks
- Vascular leak maximizes then resolves (48-72 hours)
- Myocardial dysfunction persists up to 2 weeks 4
Mixed Shock Phenotype
Dengue shock represents approximately equal contributions of hypovolemic and cardiogenic components 4. Cardiac manifestations include 1:
- Arrhythmias (most frequent)
- Myocarditis (may mimic myocardial infarction)
- Pericarditis
- Left ventricular systolic dysfunction
- Rarely: intracoronary thrombosis, coronary dissection, intramural hematoma
Men face higher risk of cardiac complications with greater rates of LV dysfunction 1.
Autoimmune Component
The immune response generates autoantibodies that cross-react with host antigens 3:
- Anti-NS1 antibodies cross-react with endothelial cells, platelets
- Anti-prM and anti-E protein antibodies target plasminogen, integrin
- This autoimmune response contributes to endothelial damage and thrombocytopenia
Host Genetic Factors
Disease severity is influenced by 3:
- Gene polymorphisms affecting immune response
- Variations in cytokine production
- Differences in receptor expression
Clinical Pitfalls
- Cardiac involvement is significantly underdiagnosed (only small percentage receive cardiac evaluation in endemic areas) 1
- The temporal dissociation between vascular leak resolution and persistent myocardial dysfunction creates a narrow therapeutic window where aggressive fluid resuscitation after defervescence may cause pulmonary edema 4
- Pediatric populations may have higher incidence of cardiac complications 1
- Any echocardiographic abnormality associates with adverse outcomes 1
Disease Progression Framework
According to WHO 2009 classification 1:
- Dengue without warning signs - self-limited febrile illness
- Dengue with warning signs - abdominal pain, persistent vomiting, fluid accumulation, mucosal bleeding, lethargy, hepatomegaly, rising hematocrit with falling platelets
- Severe dengue - plasma leakage leading to shock, severe bleeding, or organ impairment
Dengue shock syndrome includes all hemorrhagic fever criteria plus hypotension or narrow pulse pressure (≤20 mm Hg) 5.